| 1 | Circular RNA regulatory role in pathological cardiac remodelling | 6.3 | 29 | Citations (PDF) |
| 2 | Circulating Non-Coding RNAs as Indicators of Fibrosis and Heart Failure Severity | 4.6 | 21 | Citations (PDF) |
| 3 | Evolution of journal clubs: fostering collaborative learning in modern research | 2.2 | 7 | Citations (PDF) |
| 4 | Non-coding RNAs as therapeutic targets and biomarkers in ischaemic heart disease | 35.5 | 63 | Citations (PDF) |
| 5 | Development of a long noncoding RNA-based machine learning model to predict COVID-19 in-hospital mortality | 13.7 | 19 | Citations (PDF) |
| 6 | Small Extracellular Vesicles in the Pericardium Modulate Macrophage Immunophenotype in Coronary Artery Disease | 3.3 | 17 | Citations (PDF) |
| 7 | Efficacy of treatments tested in COVID-19 patients with cardiovascular disease. A meta-analysis | 1.1 | 1 | Citations (PDF) |
| 8 | Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles | 5.5 | 163 | Citations (PDF) |
| 9 | Integration of epigenetic regulatory mechanisms in heart failure | 7.0 | 25 | Citations (PDF) |
| 10 | Dissecting the transcriptome in cardiovascular disease | 5.5 | 40 | Citations (PDF) |
| 11 | Epicardium-derived extracellular vesicles: a promising avenue for cardiac regeneration | 5.5 | 0 | Citations (PDF) |
| 12 | Peripheral blood RNA biomarkers for cardiovascular disease from bench to bedside: a position paper from the EU-CardioRNA COST action CA17129 | 5.5 | 42 | Citations (PDF) |
| 13 | Pro-angiogenic approach for skeletal muscle regeneration | 2.0 | 24 | Citations (PDF) |
| 14 | NADPH-derived ROS generation drives fibrosis and endothelial-to-mesenchymal transition in systemic sclerosis: Potential cross talk with circulating miRNAs | 2.6 | 19 | Citations (PDF) |
| 15 | Effect of cardioplegic arrest and reperfusion on left and right ventricular proteome/phosphoproteome in patients undergoing surgery for coronary or aortic valve disease | 4.4 | 6 | Citations (PDF) |
| 16 | Pathology-related changes in cardiac energy metabolites, inflammatory response and reperfusion injury following cardioplegic arrest in patients undergoing open-heart surgery | 2.4 | 9 | Citations (PDF) |
| 17 | PPMS: A framework to Profile Primary MicroRNAs from Single-cell RNA-sequencing datasets | 6.6 | 10 | Citations (PDF) |
| 18 | Remote ischemic preconditioning in isolated valve intervention. A pooled meta-analysis | 2.2 | 3 | Citations (PDF) |
| 19 | To serve and protect: a new heart patrolling and recycling role for macrophages | 5.5 | 3 | Citations (PDF) |
| 20 | Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129 | 5.5 | 25 | Citations (PDF) |
| 21 | Leveraging non-coding RNAs to fight cardiovascular disease: the EU-CardioRNA network | 2.2 | 17 | Citations (PDF) |
| 22 | METTL3 Regulates Angiogenesis by Modulating let-7e-5p and miRNA-18a-5p Expression in Endothelial Cells | 6.0 | 53 | Citations (PDF) |
| 23 | Bioinspired artificial exosomes based on lipid nanoparticles carrying let-7b-5p promote angiogenesis in vitro and in vivo | 10.2 | 74 | Citations (PDF) |
| 24 | In Vivo Characterization of Endogenous Cardiovascular Extracellular Vesicles in Larval and Adult Zebrafish | 6.0 | 36 | Citations (PDF) |
| 25 | Relevance of N6-methyladenosine regulators for transcriptome: Implications for development and the cardiovascular system | 3.8 | 19 | Citations (PDF) |
| 26 | MicroRNAs as potential biomarkers in congenital heart surgery | 2.5 | 17 | Citations (PDF) |
| 27 | Changes in high-density lipoprotein microRNA might create a lasting memory of high-fat diet | 5.5 | 2 | Citations (PDF) |
| 28 | Noncoding RNAs implication in cardiovascular diseases in the COVID-19 era | 6.4 | 21 | Citations (PDF) |
| 29 | Novel Applications of Mesenchymal Stem Cell-Derived Exosomes for Myocardial Infarction Therapeutics | 4.2 | 75 | Citations (PDF) |
| 30 | Native and bioengineered extracellular vesicles for cardiovascular therapeutics | 35.5 | 451 | Citations (PDF) |
| 31 | Analysis of Neat Biofluids Obtained During Cardiac Surgery Using Nanoparticle Tracking Analysis: Methodological Considerations | 3.6 | 15 | Citations (PDF) |
| 32 | MicroRNA-24-3p Targets Notch and Other Vascular Morphogens to Regulate Post-ischemic Microvascular Responses in Limb Muscles | 4.4 | 29 | Citations (PDF) |
| 33 | Exosomes Could Offer New Options to Combat the Long-Term Complications Inflicted by Gestational Diabetes Mellitus | 4.6 | 29 | Citations (PDF) |
| 34 | Exosomes: From Potential Culprits to New Therapeutic Promise in the Setting of Cardiac Fibrosis | 4.6 | 53 | Citations (PDF) |
| 35 | Regulatory RNAs in Heart Failure | 18.0 | 177 | Citations (PDF) |
| 36 | The LINC00961 transcript and its encoded micropeptide, small regulatory polypeptide of amino acid response, regulate endothelial cell function | 5.5 | 58 | Citations (PDF) |
| 37 | Call to action for the cardiovascular side of COVID-19 | 2.2 | 12 | Citations (PDF) |
| 38 | WWP2 regulates pathological cardiac fibrosis by modulating SMAD2 signaling | 13.7 | 71 | Citations (PDF) |
| 39 | miR-15a/-16 Inhibit Angiogenesis by Targeting the Tie2 Coding Sequence: Therapeutic Potential of a miR-15a/16 Decoy System in Limb Ischemia | 5.5 | 50 | Citations (PDF) |
| 40 | Nerve growth factor gene therapy improves bone marrow sensory innervation and nociceptor-mediated stem cell release in a mouse model of type 1 diabetes with limb ischaemia | 7.5 | 21 | Citations (PDF) |
| 41 | Optimisation of laboratory methods for whole transcriptomic RNA analyses in human left ventricular biopsies and blood samples of clinical relevance | 2.3 | 15 | Citations (PDF) |
| 42 | Enhanced notch signaling modulates unproductive revascularization in response to nitric oxide‐angiopoietin signaling in a mouse model of peripheral ischemia | 1.6 | 9 | Citations (PDF) |
| 43 | Aortic morphological variability in patients with bicuspid aortic valve and aortic coarctation | 1.4 | 34 | Citations (PDF) |
| 44 | Remote ischaemic preconditioning in isolated aortic valve and coronary artery bypass surgery: a randomized trial† | 1.4 | 22 | Citations (PDF) |
| 45 | Robust Revascularization in Models of Limb Ischemia Using a Clinically Translatable Human Stem Cell-Derived Endothelial Cell Product | 10.2 | 62 | Citations (PDF) |
| 46 | Transplantation of Allogeneic Pericytes Improves Myocardial Vascularization and Reduces Interstitial Fibrosis in a Swine Model of Reperfused Acute Myocardial Infarction | 4.0 | 47 | Citations (PDF) |
| 47 | MWASTools: an R/bioconductor package for metabolome-wide association studies | 4.7 | 20 | Citations (PDF) |
| 48 | Enlightening the Association between Bicuspid Aortic Valve and Aortopathy | 1.4 | 18 | Citations (PDF) |
| 49 | Exosomes: Basic Biology and Technological Advancements Suggesting Their Potential as Ischemic Heart Disease Therapeutics | 2.8 | 47 | Citations (PDF) |
| 50 | BDNF (Brain-Derived Neurotrophic Factor) Promotes Embryonic Stem Cells Differentiation to Endothelial Cells Via a Molecular Pathway, Including MicroRNA-214, EZH2 (Enhancer of Zeste Homolog 2), and eNOS (Endothelial Nitric Oxide Synthase) | 6.0 | 44 | Citations (PDF) |
| 51 | miR-210 Enhances the Therapeutic Potential of Bone-Marrow-Derived Circulating Proangiogenic Cells in the Setting of Limb Ischemia | 10.2 | 45 | Citations (PDF) |
| 52 | Human Pericardial Fluid Contains Exosomes Enriched with Cardiovascular-Expressed MicroRNAs and Promotes Therapeutic Angiogenesis | 10.2 | 191 | Citations (PDF) |
| 53 | Methodological Guidelines to Study Extracellular Vesicles | 13.1 | 970 | Citations (PDF) |
| 54 | Extracellular vesicles at the cross‐line between basic science and clinical needs | 1.6 | 5 | Citations (PDF) |
| 55 | Transcriptional and Post-Transcriptional Gene Regulation by Long Non-Coding RNA | 6.1 | 824 | Citations (PDF) |
| 56 | Modulating microRNAs in cardiac surgery patients: Novel therapeutic opportunities? 2017, 170, 192-204 | | 15 | Citations (PDF) |
| 57 | Synthetic microparticles conjugated with VEGF165 improve the survival of endothelial progenitor cells via microRNA-17 inhibition | 13.7 | 41 | Citations (PDF) |
| 58 | The Function and Therapeutic Potential of Long Non-coding RNAs in Cardiovascular Development and Disease | 5.5 | 105 | Citations (PDF) |
| 59 | Platelet lysate gel and endothelial progenitors stimulate microvascular network formation in vitro: tissue engineering implications | 3.4 | 65 | Citations (PDF) |
| 60 | MicroRNA transport in cardiovascular complication of diabetes | 2.4 | 19 | Citations (PDF) |
| 61 | A Role for the Long Noncoding RNA SENCR in Commitment and Function of Endothelial Cells | 10.2 | 149 | Citations (PDF) |
| 62 | Type-2 diabetes increases autophagy in the human heart through promotion of Beclin-1 mediated pathway | 2.2 | 112 | Citations (PDF) |
| 63 | Coronary Artery-Bypass-Graft Surgery Increases the Plasma Concentration of Exosomes Carrying a Cargo of Cardiac MicroRNAs: An Example of Exosome Trafficking Out of the Human Heart with Potential for Cardiac Biomarker Discovery | 2.3 | 125 | Citations (PDF) |
| 64 | Copper Transport Protein Antioxidant-1 Promotes Inflammatory Neovascularization via Chaperone and Transcription Factor Function | 3.4 | 108 | Citations (PDF) |
| 65 | Migration towards SDF-1 selects angiogenin-expressing bone marrow monocytes endowed with cardiac reparative activity in patients with previous myocardial infarction | 6.6 | 13 | Citations (PDF) |
| 66 | Non coding RNAs in aortic aneurysmal disease | 2.3 | 42 | Citations (PDF) |
| 67 | Expansion and Characterization of Neonatal Cardiac Pericytes Provides a Novel Cellular Option for Tissue Engineering in Congenital Heart Disease | 4.0 | 68 | Citations (PDF) |
| 68 | Data supporting the activation of autophagy genes in the diabetic heart | 1.1 | 5 | Citations (PDF) |
| 69 | Sensory neuropathy hampers nociception-mediated bone marrow stem cell release in mice and patients with diabetes | 7.5 | 39 | Citations (PDF) |
| 70 | A Journey From Basic Stem Cell Discovery To Clinical Application: The Case of Adventitial Progenitor Cells | 2.0 | 10 | Citations (PDF) |
| 71 | Noncoding RNAs in diabetes vascular complications | 3.8 | 65 | Citations (PDF) |
| 72 | Gestational Diabetes Mellitus Impairs Fetal Endothelial Cell Functions Through a Mechanism Involving MicroRNA-101 and Histone Methyltransferase Enhancer of Zester Homolog-2 | 6.0 | 114 | Citations (PDF) |
| 73 | IL-33/ST2 in angiogenesis and limb ischemia in mice | 1.5 | 0 | Citations (PDF) |
| 74 | Epigenetic Profile of Human Adventitial Progenitor Cells Correlates With Therapeutic Outcomes in a Mouse Model of Limb Ischemia | 6.0 | 42 | Citations (PDF) |
| 75 | Exosomes and exosomal miRNAs in cardiovascular protection and repair | 2.5 | 252 | Citations (PDF) |
| 76 | MicroRNAs in vascular tissue engineering and post-ischemic neovascularization | 15.4 | 26 | Citations (PDF) |
| 77 | Combined Intramyocardial Delivery of Human Pericytes and Cardiac Stem Cells Additively Improves the Healing of Mouse Infarcted Hearts Through Stimulation of Vascular and Muscular Repair | 13.1 | 123 | Citations (PDF) |
| 78 | Cardiac Nerve Growth Factor Overexpression Induces Bone Marrow–derived Progenitor Cells Mobilization and Homing to the Infarcted Heart | 10.2 | 15 | Citations (PDF) |
| 79 | p75NTR-dependent activation of NF-κB regulates microRNA-503 transcription and pericyte–endothelial crosstalk in diabetes after limb ischaemia | 13.7 | 136 | Citations (PDF) |
| 80 | EZH2 Modulates Angiogenesis In Vitro and in a Mouse Model of Limb Ischemia | 10.2 | 69 | Citations (PDF) |
| 81 | Rapid onset of cardiomyopathy in STZ-induced female diabetic mice involves the downregulation of pro-survival Pim-1 | 9.4 | 50 | Citations (PDF) |
| 82 | Concise Review: MicroRNAs as Modulators of Stem Cells and Angiogenesis | 3.2 | 70 | Citations (PDF) |
| 83 | Ex Vivo Molecular Rejuvenation Improves the Therapeutic Activity of Senescent Human Cardiac Stem Cells in a Mouse Model of Myocardial Infarction | 3.2 | 59 | Citations (PDF) |
| 84 | Oxidative stress-dependent activation of collagen synthesis is induced in human pulmonary smooth muscle cells by sera from patients with scleroderma-associated pulmonary hypertension | 3.1 | 44 | Citations (PDF) |
| 85 | Migratory Activity of Circulating Mononuclear Cells Is Associated With Cardiovascular Mortality in Type 2 Diabetic Patients With Critical Limb Ischemia | 6.2 | 15 | Citations (PDF) |
| 86 | Pre-emptive hypoxia-regulated HO-1 gene therapy improves post-ischaemic limb perfusion and tissue regeneration in mice | 5.5 | 48 | Citations (PDF) |
| 87 | Boosting the pentose phosphate pathway restores cardiac progenitor cell availability in diabetes | 5.5 | 66 | Citations (PDF) |
| 88 | Blood flow and stem cells in vascular disease | 5.5 | 45 | Citations (PDF) |
| 89 | Local Inhibition of MicroRNA-24 Improves Reparative Angiogenesis and Left Ventricle Remodeling and Function in Mice With Myocardial Infarction | 10.2 | 142 | Citations (PDF) |
| 90 | Global Remodeling of the Vascular Stem Cell Niche in Bone Marrow of Diabetic Patients | 13.1 | 155 | Citations (PDF) |
| 91 | Diabetes Causes Bone Marrow Endothelial Barrier Dysfunction by Activation of the RhoA–Rho-Associated Kinase Signaling Pathway | 6.0 | 72 | Citations (PDF) |
| 92 | You can teach an old dog new tricks: angiopoietin‐1 instructs Tie2
pos
myeloid cells to promote neovascularization in ischemic limbs | 7.1 | 3 | Citations (PDF) |
| 93 | Perivascular Delivery of Encapsulated Mesenchymal Stem Cells Improves Postischemic Angiogenesis Via Paracrine Activation of VEGF-A | 6.0 | 69 | Citations (PDF) |
| 94 | MicroRNA-15a and MicroRNA-16 Impair Human Circulating Proangiogenic Cell Functions and Are Increased in the Proangiogenic Cells and Serum of Patients With Critical Limb Ischemia | 13.1 | 195 | Citations (PDF) |
| 95 | Soluble ST2 Is Regulated by p75 Neurotrophin Receptor and Predicts Mortality in Diabetic Patients With Critical Limb Ischemia | 6.0 | 44 | Citations (PDF) |
| 96 | Role for Substance P–Based Nociceptive Signaling in Progenitor Cell Activation and Angiogenesis During Ischemia in Mice and in Human Subjects | 18.0 | 98 | Citations (PDF) |
| 97 | MicroRNAs in Postischemic Vascular Repair | 2.1 | 32 | Citations (PDF) |
| 98 | Nerve Growth Factor Gene Therapy Using Adeno-Associated Viral Vectors Prevents Cardiomyopathy in Type 1 Diabetic Mice | 4.2 | 42 | Citations (PDF) |
| 99 | Role of microRNAs in diabetes and its cardiovascular complications | 5.5 | 254 | Citations (PDF) |
| 100 | Apricot Melanoidins Prevent Oxidative Endothelial Cell Death by Counteracting Mitochondrial Oxidation and Membrane Depolarization | 2.3 | 57 | Citations (PDF) |
| 101 | Role of MicroRNAs 99b, 181a, and 181b in the Differentiation of Human Embryonic Stem Cells to Vascular Endothelial Cells | 3.2 | 95 | Citations (PDF) |
| 102 | Vascular differentiation from embryonic stem cells: Novel technologies and therapeutic promises | 2.5 | 51 | Citations (PDF) |
| 103 | Deregulation of microRNA-503 Contributes to Diabetes Mellitus–Induced Impairment of Endothelial Function and Reparative Angiogenesis After Limb Ischemia | 18.0 | 395 | Citations (PDF) |
| 104 | MicroRNA-503 and the Extended MicroRNA-16 Family in Angiogenesis | 7.2 | 84 | Citations (PDF) |
| 105 | Pluripotent stem cell differentiation into vascular cells: A novel technology with promises for vascular re(generation) 2011, 129, 29-49 | | 97 | Citations (PDF) |
| 106 | MicroRNA regulation in angiogenesis | 2.5 | 167 | Citations (PDF) |
| 107 | Tissue Kallikrein Is Essential for Invasive Capacity of Circulating Proangiogenic Cells | 13.1 | 57 | Citations (PDF) |
| 108 | Intravenous Gene Therapy With PIM-1 Via a Cardiotropic Viral Vector Halts the Progression of Diabetic Cardiomyopathy Through Promotion of Prosurvival Signaling | 13.1 | 141 | Citations (PDF) |
| 109 | Transplantation of Human Pericyte Progenitor Cells Improves the Repair of Infarcted Heart Through Activation of an Angiogenic Program Involving Micro-RNA-132 | 13.1 | 350 | Citations (PDF) |
| 110 | Involvement of Phosphoinositide 3-Kinase γ in Angiogenesis and Healing of Experimental Myocardial Infarction in Mice | 13.1 | 82 | Citations (PDF) |
| 111 | Neurotrophin-3 Is a Novel Angiogenic Factor Capable of Therapeutic Neovascularization in a Mouse Model of Limb Ischemia | 6.0 | 63 | Citations (PDF) |
| 112 | Nerve Growth Factor Promotes Cardiac Repair following Myocardial Infarction | 13.1 | 189 | Citations (PDF) |
| 113 | Inhibition of Delta-Like-4–Mediated Signaling Impairs Reparative Angiogenesis After Ischemia | 13.1 | 81 | Citations (PDF) |
| 114 | Human Adult Vena Saphena Contains Perivascular Progenitor Cells Endowed With Clonogenic and Proangiogenic Potential | 18.0 | 293 | Citations (PDF) |
| 115 | Vitamin B1 Analog Benfotiamine Prevents Diabetes-Induced Diastolic Dysfunction and Heart Failure Through Akt/Pim-1–Mediated Survival Pathway | 4.4 | 92 | Citations (PDF) |
| 116 | Diabetes Mellitus Induces Bone Marrow Microangiopathy | 6.0 | 229 | Citations (PDF) |
| 117 | Derivation of Endothelial Cells From Human Embryonic Stem Cells by Directed Differentiation | 6.0 | 151 | Citations (PDF) |
| 118 | Benfotiamine improves functional recovery of the infarcted heart via activation of pro-survival G6PD/Akt signaling pathway and modulation of neurohormonal response | 3.8 | 71 | Citations (PDF) |
| 119 | Critical Role of Tissue Kallikrein in Vessel Formation and Maturation | 6.0 | 74 | Citations (PDF) |
| 120 | Cardiovascular Actions of Neurotrophins | 25.4 | 191 | Citations (PDF) |
| 121 | Human CD133
+
Progenitor Cells Promote the Healing of Diabetic Ischemic Ulcers by Paracrine Stimulation of Angiogenesis and Activation of Wnt Signaling | 13.1 | 253 | Citations (PDF) |
| 122 | Possible novel targets for therapeutic angiogenesis | 3.8 | 38 | Citations (PDF) |
| 123 | Human fetal aorta-derived vascular progenitor cells: identification and potential application in ischemic diseases | 1.4 | 16 | Citations (PDF) |
| 124 | Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies | 5.5 | 142 | Citations (PDF) |
| 125 | Neurotrophin p75 Receptor (p75
NTR
) Promotes Endothelial Cell Apoptosis and Inhibits Angiogenesis | 13.1 | 93 | Citations (PDF) |
| 126 | Role of Kinin B2Receptor Signaling in the Recruitment of Circulating Progenitor Cells With Neovascularization Potential | 13.1 | 115 | Citations (PDF) |
| 127 | Phosphoinositide 3-Kinase γ Gene Knockout Impairs Postischemic Neovascularization and Endothelial Progenitor Cell Functions | 6.0 | 80 | Citations (PDF) |
| 128 | Genetic and dietary control of plasma tissue kallikrein secretion and urinary kinins exretion in man | 2.1 | 17 | Citations (PDF) |
| 129 | Human Fetal Aorta Contains Vascular Progenitor Cells Capable of Inducing Vasculogenesis, Angiogenesis, and Myogenesis in Vitro and in a Murine Model of Peripheral Ischemia | 3.4 | 97 | Citations (PDF) |
| 130 | Mechanisms of Disease: the tissue kallikrein–kinin system in hypertension and vascular remodeling | 3.2 | 124 | Citations (PDF) |
| 131 | Nitropravastatin stimulates reparative neovascularisation and improves recovery from limb Ischaemia in type‐1 diabetic mice | 6.3 | 48 | Citations (PDF) |
| 132 | Identification of the prosurvival activity of nerve growth factor on cardiac myocytes | 13.3 | 98 | Citations (PDF) |
| 133 | Type-2 Diabetic Leprdb/db Mice Show a Defective Microvascular Phenotype under basal conditions and an Impaired Response to Angiogenesis Gene Therapy in the setting of Limb Ischemia | 5.8 | 40 | Citations (PDF) |
| 134 | Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis | 7.5 | 81 | Citations (PDF) |
| 135 | Murine models of myocardial and limb ischemia: Diagnostic end-points and relevance to clinical problems | 2.5 | 51 | Citations (PDF) |
| 136 | Therapeutic angiogenesis: Translating experimental concepts to medically relevant goals | 2.5 | 23 | Citations (PDF) |
| 137 | Diagnostic tools for the study of vascular cognitive dysfunction in hypertension and antihypertensive drug research 2006, 109, 274-283 | | 16 | Citations (PDF) |
| 138 | Regional and global protective effects of tissue kallikrein gene delivery to the peri-infarct myocardium | 2.0 | 26 | Citations (PDF) |
| 139 | Antiangiogenesis Mediates Cisplatin-Induced Peripheral Neuropathy | 18.0 | 78 | Citations (PDF) |
| 140 | Genetic Deletion of the p66
Shc
Adaptor Protein Protects From Angiotensin II–Induced Myocardial Damage | 6.6 | 106 | Citations (PDF) |
| 141 | Changing the logic of therapeutic angiogenesis for ischemic disease | 7.4 | 17 | Citations (PDF) |
| 142 | In search of the best candidate for regeneration of ischemic tissues. Are embryonic/fetal stem cells more advantageous than adult counterparts? | 4.1 | 10 | Citations (PDF) |
| 143 | Transplantation of low dose CD34
+
Kdr
+
cells promotes vascular and muscular regeneration in ischemic limbs | 0.6 | 122 | Citations (PDF) |
| 144 | Akt/Protein Kinase B and Endothelial Nitric Oxide Synthase Mediate Muscular Neovascularization Induced by Tissue Kallikrein Gene Transfer | 18.0 | 63 | Citations (PDF) |
| 145 | Nitric Oxide–Releasing Aspirin Derivative, NCX 4016, Promotes Reparative Angiogenesis and Prevents Apoptosis and Oxidative Stress in a Mouse Model of Peripheral Ischemia | 6.0 | 33 | Citations (PDF) |
| 146 | Circulating Tissue Kallikrein Levels Correlate With Severity of Carotid Atherosclerosis | 6.0 | 23 | Citations (PDF) |
| 147 | Genetically Engineered Stem Cell Therapy for Tissue Regeneration | 4.0 | 57 | Citations (PDF) |
| 148 | Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of Type 1 diabetic mice | 7.5 | 128 | Citations (PDF) |
| 149 | Nerve growth factor supplementation reverses the impairment, induced by Type 1 diabetes, of hindlimb post-ischaemic recovery in mice | 7.5 | 74 | Citations (PDF) |
| 150 | Paracrine control of vascularization and neurogenesis by neurotrophins | 6.3 | 59 | Citations (PDF) |
| 151 | Cardiac Hypertrophy and Microvascular Deficit in Kinin B2 Receptor Knockout Mice | 6.6 | 68 | Citations (PDF) |
| 152 | Letter to the Editor | 6.6 | 7 | Citations (PDF) |
| 153 | Protease-Activated Receptor-2 Stimulates Angiogenesis and Accelerates Hemodynamic Recovery in a Mouse Model of Hindlimb Ischemia | 13.1 | 77 | Citations (PDF) |
| 154 | Prevention of Diabetes-Induced Microangiopathy by Human Tissue Kallikrein Gene Transfer | 18.0 | 80 | Citations (PDF) |
| 155 | Ramipril improves hemodynamic recovery but not microvascular response to ischemia in spontaneously hypertensive rats | 2.0 | 12 | Citations (PDF) |
| 156 | Nerve Growth Factor Promotes Angiogenesis and Arteriogenesis in Ischemic Hindlimbs | 18.0 | 262 | Citations (PDF) |
| 157 | Angiotensin AT1
receptor signalling modulates reparative angiogenesis induced by limb ischaemia | 6.3 | 51 | Citations (PDF) |
| 158 | Role of calcitonin gene-related peptide and kinins in post-ischemic intestinal reperfusion | 2.8 | 12 | Citations (PDF) |
| 159 | Targeting kinin receptors for the treatment of tissue ischaemia | 11.4 | 46 | Citations (PDF) |
| 160 | Renal phenotype of low kallikrein rats | 5.3 | 21 | Citations (PDF) |
| 161 | Angiogenesis gene therapy to rescue ischaemic tissues: achievements and future directions | 6.3 | 52 | Citations (PDF) |
| 162 | Participation of kinins in the captopril-induced inhibition of intimal hyperplasia caused by interruption of carotid blood flow in the mouse | 6.3 | 12 | Citations (PDF) |
| 163 | Studies of the cardiovascular effects of nociceptin and related peptides | 2.8 | 23 | Citations (PDF) |
| 164 | Altered baroreflex control of heart rate in bradykinin B2-receptor knockout mice | 3.6 | 20 | Citations (PDF) |
| 165 | Role of the bradykinin B2 receptor in the maturation of blood pressure phenotype: lesson from transgenic and knockout mice | 3.6 | 30 | Citations (PDF) |
| 166 | The bradykinin B1
receptor and the central regulation of blood pressure in spontaneously hypertensive rats | 6.3 | 35 | Citations (PDF) |
| 167 | Role of the kallikrein–kinin system in the maturation of cardiovascular phenotype | 2.0 | 19 | Citations (PDF) |
| 168 | Role of nitric oxide synthase inhibition in the acute hypertensive response to intracerebroventricular cadmium | 6.3 | 44 | Citations (PDF) |
| 169 | Characterization of the endothelin receptor subtype mediating epithelium‐derived relaxant nitric oxide release from guinea‐pig trachea | 6.3 | 14 | Citations (PDF) |
| 170 | Endogenous Nitric Oxide Inhibits Bronchoconstriction Induced by Cold-Air Inhalation in Guinea Pigs: Role of Kinins | 8.9 | 31 | Citations (PDF) |
| 171 | Blood pressure responses to acute or chronic captopril in mice with disruption of bradykinin B2-receptor gene | 2.1 | 22 | Citations (PDF) |
| 172 | The control of microvascular permeability and blood pressure by neutral endopeptidase | 33.0 | 156 | Citations (PDF) |
| 173 | EFFECT OF EARLY BLOCKADE OF BRADYKININ B2-RECEPTORS ON THE BLOOD PRESSURE PHENOTYPE OF NORMOTENSIVE AND SPONTANEOUSLY HYPERTENSIVE RATS | 9.1 | 8 | Citations (PDF) |
| 174 | Substance P and bradykinin stimulate plasma extravasation in the mouse gastrointestinal tract and pancreas | 3.2 | 53 | Citations (PDF) |
| 175 | Differential activation of the epithelial and smooth muscle NK1
receptors by synthetic tachykinin agonists in guinea-pig trachea | 6.3 | 13 | Citations (PDF) |
| 176 | Regulation of bradykinin B 2‐receptor expression by oestrogen | 6.3 | 69 | Citations (PDF) |
| 177 | Cardiovascular Phenotype of a Mouse Strain With Disruption of Bradykinin B2-Receptor Gene | 18.0 | 122 | Citations (PDF) |
| 178 | Evidence that tachykinins relax the guinea‐pig tracheavianitric oxide release and by stimulation of a septide‐insensitive NK1receptor | 6.3 | 31 | Citations (PDF) |
| 179 | Harnessing multiomics technologies and machine learning for advancing personalized theranostic approaches in atherosclerosis | 15.7 | 2 | Citations (PDF) |
| 180 | Left and right myocardial ventricular energetics during cardioplegic ischemic arrest and reperfusion in patients undergoing cardiac surgery | 3.8 | 0 | Citations (PDF) |
| 181 | Severe hypoxia drives loss of ST6GAL1-mediated α2,6-sialylation in the epicardial secretome impairing angiogenic activity | 1.2 | 0 | Citations (PDF) |
